Association of genetic defects in primary resected lung adenocarcinoma revealed by targeted allelic imbalance analysis

American Journal of Respiratory Cell and Molecular Biology

Volumn 27, Issue 4, 2002, Pages 495-502

  Cave Riant, Florence ^a   Cuillerier, Benoit ^a   Beau Faller, Michèle ^a   Martinet, Nadine ^a   Alla, François ^a   Bronner, Christian ^a   Schneider, Anne ^a   Oudet, Pierre ^a   Gaub, Marie Pierre ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0036787905     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.4800     Document Type: Article

References (52)

1. Ernster, V. L. 1996. Female lung cancer. Annu. Rev. Public Health 17:97-114.
2. Levi, F., L. A. Vecchia, C. Lucchini, and F. E. Negri. 1996. World wide trends in cancer mortality in the elderly, 1955-1992. Eur. J. Cancer 32:652-672.
3. Frieberg, J. S., and L. R. Kelser. 1997. Epidemiology of lung cancer. Semin. Thorac. Cardiovasc. Surgery 9:56-59.
4. Mountain, C. F. 1997. Revisions in the international system for staging lung cancer. Chest 111:1710-1717.
5. Valaitis, J., S. Warren, and D. Gamble. 1981. Increasing incidence of adenocarcinoma of the lung. Cancer 47:1042-1046.
6. Andrews, J. L., S. Bloom, K. Balogh, and J. F. Beamis. 1985. Lung cancer in women: Lahey clinic experience, 1957-1980. Cancer 55:2894-2898.
7. Thun, M. J., C. A. Lally, J. T. Flannery, E. E. Calle, W. D. Flanders and C. W. Heath, Jr. 1997. Cigarette smoking and changes in the histopathology of lung cancer. J. Nat. Cancer Inst. 89:1580-1586.
8. Charloux, A., E. Quoix, N. Wolkowe, D. Small, G. Pauli, and H. Kreisman. 1997. The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma. Int. J. Epidemiol 26:14-23.
9. Ilyas, M., J. Straub, I. P. M. Tomlinson, and W. F. Bodmer. 1999. Genetic pathways in colorectal and other cancers. Ear. J. Cancer 35:335-351.
10. Lengauer, C., K. W. Kintzler, and B. Vogelstein. 1998. Genetic instabilities in human cancers. Nature 396:643-649.
11. Chung, D. C. 2000. The genetic basis of colorectal cancer: insights into critical pathways of tumorogenesis. Gastroenterology 119:854-865.
12. Marchetti, A., C. Doglioni, M. Barbareschi, F. Buttitta, S. Pellegrini, P. Gaeta, R. La Rocca, G. Merlo, A. Chella, C.A. Angeletti, P. Dalla Palma, and G. Bevilacqua. 1998. Cyclin D1 and retinoblastoma susceptibility gene alterations in non-small cell lung cancer. Int. J. Cancer 75: 187-192.
13. Hunchareck, M., J. Muscat, and J. F. Geschwind. 1999. K-ras oncogene mutation as a prognostic marker in non-small cell lung cancer: a combined analysis of 881 cases. Carcinogenesis 20:1507-1510.
14. Cairns, P., T. J. Polascik, Y. Eby, K. Tokino, J. Califano, A. Merlo, L. Mao, J. Herath, R. Jenkins, W. Westra, J. L. Rutter, A. Buckler, E. Gabrielson, M. Tockman, K. R. Cho, L. Hedrick, G. S. Bova, W. Isaacs, W. Koch, D. Schwab, and D. Sidransky. 1995. Frequency of homozygous deletion at pl6/CDKN2 in primary human tumors. Nature Genet. 11:210-212.
15. INK4a expression in resected non-small cell lung tumors. Cancer Res. 56:3415-3420.
16. INK4 and retinoblastoma protein status in non-small cell lung cancer: potential synergistic effect with altered p53 protein on proliferative activity. Cancer Res. 56:5557-5562.
17. INK4A inactivation in non small-cell lung cancers. Oncogene 16:497-504.
18. Martinet, N., F. Alla, G. Farré T. Labib, H. Drouot, R. Vidili, E. Picard, M. P. Gaub, D. Le Faou, J. Siat, J. Borelly, P. Vermylen, T. Bazarbachi, J. M. Vignaud, and Y. Martinet. 2000. Retinoic acid receptor and retinoid X receptor alterations in lung cancer precursor lesions. Cancer Res. 60:2869-2875.
19. Campedes-Cespedes, M., S. A. Ahrendt, S. Piantadosi, R. Rosell, M. Monzo, L. Wu, W. H. Westra, S. C. Yang, J. Jen, and D. Sidransky. 2001. Chromosomal alterations in lung adenocarcinoma from smokers and non-smokers. Cancer Res. 61:1309-1313.
20. Balsara, B. R., G. Sonoda, S. Du Manoir, J. M. Siegfried, E. Gabrielson, and J. R. Testa. 1997. Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Res. 57:2116-2120.
21. Fong, K. M., Y. Kida, P. V. Zimmerman, M. Ikenaga, and P. J. Smith. 1995. Loss of heterozygosity frequently affects chromosome 17q in non-small cell lung cancer. Cancer Res. 55:4268-4272.
22. Neville, E. M., M. P. Stewart, A. Swift, T. Liloglou, H. Ross, J. R. Gosney, R. J. Donnelly, and J. K. Field. 1996. Allelotype of non-small cell lung cancer. Int. J. Oncol. 9:533-539.
23. Virmani, A. K., K. M. Fong, D. Kodagoda, D. McIntire, J. Hung, V. Tonk, J. D. Minna, and A. F. Gazdar. 1998. Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types. Genes Chromosomes Cancer 21:308-319.
24. Huncharek, M., B. Kupelnick, J. F. Geschwind, and J. F. Caubet. 2000. Prognostic significance of p53 mutations in non-small cell lung cancer: a meta-analysis of 829 cases from eight published studies. Cancer Lett. 153:219-226.
25. Niederacher, D., F. Picard, C. Van Roeyen, H. X. An, H. G. Benderand, and M. W. Beckmann. 1997. Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis. Genes Chromosomes Cancer 18:181-192.
26. Mao, L., J. S. Lee, J. M. Kurie, Y. H. Fan, S. M. Lippman, J. J. Lee, J. Y. Ro, A. Broxson, R. Yu, R. C. Morice, B. L. Kemp, F. R. Khuri, G. L. Walsh, W. N. Hittelman, and W. H. Hong. 1997. Clonal genetic alterations in the lungs of current and former smokers.
27. Park, I.-W., I. I. Wistuba, A. Maitra, S. Milchgrub, A. K. Virmani, J. D. Minna, and A. F. Gazdar. 1999. Multiple clonal abnormalities in the bronchial epithelium patients with lung cancer. J. Natl. Cancer Inst. 91:1863-1868.
28. Wistuba, I. I., S. Lam, C. Behrens, A. K. Virmani, K. M. Fong, J. Leriche, J. M. Samet, S. Srivastava, J. D. Minna, and A. F. Gazdar. 1997. Molecular damage in the bronchial epithelium of current and former smokers. J. Natl. Cancer Inst. 89:1366-1373.
29. Jones, M. H., and Y. Nakamura. 1992. Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chromosomes Cancer 5:89-90.
30. Cannon Albright, L. A., D. E. Goldgar, S. Neuhausen, N. A. Gruis, D. E. Anderson, C. M. Lewis, M. Jost, T. D. Tran, K. Nyguen, A. Kamb, J. Weaver-Feldhaus, L. J. Meyer, J. J. Zone, and M. H. Skolnick. 1994. Localization of the 9p melanoma susceptibility locus (MLM) to a 2-cM region between D9S736 and D9S171. Genomics 23:265-268.
31. Parsons, R., L. L. Myeroff, B. Liu, J. K. V. Willson, S. D. Markowitz, K. W. Kinzler, and B. Vogelstein. 1995. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res. 55:5548-5550.
32. Schneider, A., S. Borgnat, H. Lang, O. Regine, V. Lindner, M. Kassem, C. Saussine, P. Oudet, D. Jacqmin, and M.-P. Gaub. 2000. Evaluation of microsatellite analysis in urine sediment for diagnosis of bladder cancer. Cancer Res. 60:4617-4622.
33. Sugano, K., Y. Nakashima, K. Yamaguchi, N. Fukayama, M. Maekawa, H. Ohkura, T. Kakizoe, and T. Sekiya. 1996. Sensitive detection of loss of heterozygosity in the Tp53 gene in pancreatic adenocarcinoma by fluorescence-based single-strand conformation polymorphism analysis using bluntend DNA fragments. Genes Chromosomes Cancer 15:157-164.
34. Weber, J. C., A. Schneider, S. Rohr, H. Nakano, P. Bachellier, A. Méchine, G. Hamel, M. Kanor, M. P. Chenard, M. P. Gaub, P. Oudet, C. Meyer, and D. Jaeck. 2001. Analysis of allelic imbalance in patients with colorectal cancer according to stage and presence of synchronous liver metastases. Ann. Surg. 6:795-803.
35. Pylkkanen, L., A. Karjalainen, S. Anttila, H. Vainio, and K. Husgafvel-Pursiainen. 1997. No evidence of microsatellite instability but frequent loss of heterozygosity in primary resected lung cancer. Environ. Mol. Mutagen. 30:217-223.
36. Benachenhou, N., S. Guiral, I. Gorska-Flipot, D. Labuda, and D. Sinnett. 1998. High resolution deletion mapping reveals frequent allelic losses at the DNA mismatch repair loci hMLH1 and hMSH3 in non-small cell lung cancer. Int. J. Cancer 77:173-180.
37. Tsuchiya, E., Y. Nakamura, S. Y. Weng, K. Nakagawa, S. Tsuchiya, H. Sugand, and T. Kitagawa. 1992. Allelotype of non-small cell carcinoma: comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res. 52:2478-2481.
38. Sato, S., Y. Nakamura, and E. Tsuchiya. 1994. Difference of allelotype between squamous-cell carcinoma and adenocarcinoma of the lung. Cancer Res. 54:5652-5655.
39. Thiberville, L., P. Payne, J. Vielkinds, J. Leriche, D. Horsman, G. Nouvet, B. Palcic, and S. Lam. 1995. Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus. Cancer Res. 55:5133-5139.
40. Zhou, X., B. L. Kemp, F. R. Khuri, D. Liu, J. J. Lee, W. Wu, W. K. Hong, and L. Mao. 2000. Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer. Clin. Cancer Res. 6:559-565.
41. Liloglou, T., P. Maloney, G. Xinarianos, S. Fear, and J. K. Field. 2000. Sensitivity and limitations of high throughput fluorescent microsatellite analysis for the detection of allelic imbalance: application in lung tumors. Int. J. Oncol. 16:5-14.
42. Shtivelman, E., B. Lifshitz, R. P. Gale, and E. Canaani. 1985. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 315:550-554.
43. Nobori, T., K. Miura, D. J. Wu, A. Lois, K. Takabayashi, and D. A. Carson. 1994. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753-756.
44. Kamb, A., N. A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshmam, S. V. Tavtigian, E. Stockert, R. S. Day III, B. E. Johnson, and M. H. Skolnick, 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
45. Cayuela, J. M., A. Madani, L. Sahnes, M. H. Stern, and F. Signaux. 1996. Multiple tumor-suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia. Blood 87:2180-2186.
46. 1 control gene status is frequently altered in resectable non-small cell lung cancer. Int. J. Cancer (Pred. Oncol.) 74:556-562.
47. Takanami, I., T. Imamuma, T. Hashizume, K. Kikuchi, Y. Yamamoto, T. Yamamoto, and S. Kodair. 1996. Expression of PDGF, IGF-II, bFGF and TGF-beta 1 in pulmonary adenocarcinoma. Pathol. Res. Pract. 192:1113-1120.
48. de Jonge, R. R., L. Garrigue-Antar, V. F. Vellucci, and M. Reiss. 1997. Frequent inactivation of the transforming growth factor beta type II receptor in small-cell lung carcinoma cells. Oncol. Res. 9:89-98.
49. Kim, T. K., E. K. Mo, C. G. Yoo, C. T. Lee, S. K. Han, Y. S. Shim, and Y. W. Kim. 2001. Alteration of cell growth and morphology by overexpression of tranforming growth factor beta type II receptor in human lung adenocarcinoma cells. Lung Cancer 31:181-191.
50. Vonlanthen, S., J. Heigway, M. P. Tschan, M. M. Borner, H. J. Altermatt, A. Kappeler, A. Tobler, M. F. Fey, N. Thatcher, W. G. Yarbrough, and D. C. Betticher. 1998. Expression of p16INK4a/p16α and p19ARF/p16β is frequently altered in non-small cell lung cancer and correlates with p53 overexpression. Oncogene 17:2779-2785.
51. Naruke, T., R. Tsuchiva, H. Kondo, H. Asamura, and H. Nakayama. 1997. Implications of staging in lung cancer. Chest 112:242S-248S.
52. Chen, X. Q., M. Stroun, J.-L. Magnenat, L. P. Nicod, A.-M. Kurt, J. Lyautey, C. Lederrey, and P. Anker. 1996. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat. Med. 2:1033-1034.